Riskpilot← Back to searchSign inGet full accessLäkarkonsult I Markström AB
ABActiveOrg 5569981599Brogatan 6Medical specialists activities · NACE 8622Est. 20141 employees
Revenue 2025
SEK 456K
-50% vs 2024
EBITDA margin
-12.3%
-115% vs 2024
Equity ratio
35.2%
Financial strength
Net profit 2025
SEK 34K
-85% vs 2024
| Revenue | SEK 456K | -50% |
| EBITDA | SEK -56K | -115% |
| Net profit | SEK 34K | -85% |
| Total assets | SEK 1,3M | -23% |
| Equity | SEK 463K | -27% |
| Employees | 1 | — |
Legal name
Läkarkonsult I Markström AB
Org number
5569981599
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
22 december 2014
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bedriva uthyrning av personal inom vård, handel med värdepapper och därmed förenlig verksamhet.
Address
Brogatan 6
Email
ingemar.markstrom@skelleftea.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 1 219 | 1 111 | 953 | 903 | 456 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 784 | 539 | 437 | 372 | −56 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 784 | 539 | 437 | 372 | −56 |
| Net financials | — | −1 | 12 | 20 | 7 |
| Profit before tax | 588 | 403 | 336 | 291 | 50 |
| Tax | −121 | −84 | −71 | −63 | −16 |
| Net profit | 467 | 319 | 265 | 228 | 34 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 1 713 | 1 662 | 1 717 | 1 702 | 1 316 |
| Equity | 517 | 545 | 615 | 638 | 463 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 820 | 605 | 477 | 338 | 226 |
| Total debt | 820 | 605 | 477 | 338 | 226 |
EBITDA margin
-12.3%
This company
15.8%
Market median
-178% vs market
20212025
Equity ratio
35.2%
This company
38.2%
Market median
+8% vs market
20212025
Return on equity
7.3%
This company
18.4%
Market median
-60% vs market
20212025
Net profit margin
7.5%
This company
8.1%
Market median
-7% vs market
20212025
Asset turnover
0.35×
This company
1.12×
Market median
-69% vs market
20212025
Debt / equity
1.84×
This company
0.62×
Market median
-197% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
SI Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Läkarkonsult I Markström AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Stig Ingemar Markström | Chief Executive Officer | 0 companies |
| Karin Maria Vikman | Deputy Board Member | 0 companies |